Albany, NY -- (SBWIRE) -- 11/08/2017 -- According to a new market report published by Transparency Market Research (www.transparencymarketresearch.com) "Zygomatic and Pterygoid Implants Market (Length of Implant: Upto 30 mm, 31-40 mm, 41-50 mm, and Above 50 mm; Application: Severe Atrophy of Maxillary Bone, Maxillary Sinuses, and Others; End User: Multispecialty Hospitals and Dental Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017-2025" the global zygomatic and pterygoid implants market was valued at US$ 211.4 Mn in 2016 and is estimated to reach US$ 350.2 Mn by 2025 at a CAGR of 5.9% from 2017 to 2025
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=33434
Zygomatic and Pterygoid implants is new and innovative technique which is used for rehabilitation of severe atrophy of maxillofacial bone. To treat severely resorbed maxillae grafting is currently the gold standard procedure, but it has low success rate that is about 50% to 60% in comparison with graft less solution such as zygomatic and pterygoid has success rate of 97% to 99.5%.These implants are used as alternative to conventional implants in cases where deficient upper jaw bone. Zygomatic implants are implanted into both side of existing zygoma bone to support a full upper set of replacement teeth. Pterygoid implant insertion is an alternative to avoid sinus-lifting or other grafting procedures to treat the posterior maxilla.
The global zygomatic and pterygoid implants market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Europe dominated the global zygomatic and pterygoid implants market in 2016 in terms of value, and is expected to continue the dominance during the forecast period. Rising number of pharmaceutical companies focusing devolvement of new and advanced dental implants for atrophy of maxillofacial bone is expected to drive the growth of market in Europe. Moreover, rising prevalence of edentulism in the region, develops high demand for zygomatic and pterygoid implants to treat such condition is expected to propel the growth of zygomatic and pterygoid implants market over forecast period. According to the European Commission, almost 33% of Europeans that do not have all their natural teeth wear a removable denture. Continuous use of dentures may rupture the facial bone or cause damage to it. In the atrophy of maxillary bone, placing dental implants is difficult, as there is no support for implants. In such cases, zygomatic and pterygoid implants becomes an option.
Moreover, rising awareness about zygomatic and pterygoid implants in countries such as Germany and the U.K. is expected to boost the market in the region. Companies such as Noble Biocare are conducting certified courses for educating dental surgeons about zygomatic and pterygoid implants.
Request to view Sample Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=33434
North America accounted for the second largest share of the global zygomatic and pterygoid implants market in terms of value. Increase in development of newer and advanced therapy such as bone graftless solution to treat conditions such as maxillary sinus and severe atrophy of maxillofacial bone is expected to boost the growth of zygomatic and pterygoid implants market in North America. The market leader of zygomatic and pterygoid implants, Danaher Corporation is based in Washington, U.S. The company is focusing on mergers and acquisitions to strengthen their product portfolio and increase brand share in the market. In January 2015, Danaher Corporation announced that it had acquired 98% shares of Nobel Biocare, a Switzerland-based dental implants company, for US$ 2.2 Bn. Through this acquisition, the company expanded presence in the dental implants segment. Nobel Biocare is a pioneer in zygomatic implants. The acquisition of Nobel Biocare has enhanced Danaher Corporation's product portfolio.
Asia Pacific is expected to register highest CAGR among the regions in the global zygomatic and pterygoid implants market during the forecast period of 2017-2025. Japan is expected to register high growth in terms of CAGR owing to presence of high consumer base for zygomatic and pterygoid implants. Developing countries such as and India, China offer lucrative growth prospects in the zygomatic and pterygoid implants market due to factors such as improving health care infrastructure, rising private and public investment, and advancements in disease treatment. In addition, growing demand for new products and advanced technologies, is expected to boost the growth of zygomatic and pterygoid implants market over the forecast period. Latin America, and the Middle East and Africa regions accounted for smaller shares in the global zygomatic and pterygoid implants market in 2016. The Middle East & Africa is expected to show sluggish growth over the forecast period owing to high cost of implants and less awareness about zygomatic and pterygoid implants.
Major players in the global zygomatic and pterygoid implants market include Danaher Corporation, Straumann Holding AG, Noris Medical, S.I.N. Implant System, Silimed, Southern Implants, Implance, Jeil Medical Corporation, and Titaniumfix among other local and regional players.
Zygomatic and Pterygoid Implants Market Market Report is available @ US$ 5795
https://www.transparencymarketresearch.com/checkout.php?rep_id=33434